GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Short-Term Debt & Capital Lease Obligation

Denis Chem Lab (BOM:537536) Short-Term Debt & Capital Lease Obligation : ₹6 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Denis Chem Lab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹6 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Denis Chem Lab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹5 Mil.


Denis Chem Lab Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Denis Chem Lab's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Short-Term Debt & Capital Lease Obligation Chart

Denis Chem Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 113.57 51.17 10.41 10.13 5.94

Denis Chem Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.13 - 12.06 - 5.94

Denis Chem Lab Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Denis Chem Lab Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines